8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Waters raises 2026 outlook after second-quarter revenue tops guidance
Filed with the SEC on · Summarized by InvestorsBot
Waters reported second-quarter 2026 revenue of $1.645 billion for the period ended July 4, including $828 million of organic revenue, up 9% in constant currency, and $817 million from its acquired Biosciences and Diagnostic Solutions businesses. Adjusted EPS was $3.05, while GAAP EPS was a loss of $1.39 due largely to acquisition-related charges; Waters raised its full-year guidance to 7%-9% organic constant-currency revenue growth, $6.415 billion-$6.476 billion in total revenue, and adjusted EPS of $14.45-$14.65.